Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Tan Sheet

Executive Summary

Morris joins CHPA federal affairs team; Fuson moves from FDA to consulting firm; Creative Edge Nutrition adds VP; former EPA executive joins Procter & Gamble sustainability panel; USANA strengthens scientist roster; more People In Brief.

You may also be interested in...



In Brief

Pernix, SEEK prep new cough med; FDA warns Quadex over herpes reference; NuMe progresses on prebiotic program; Creative Edge Nutrition expands; Reaction Nutrition records lacking; more news In Brief.

P&G Pushes Suppliers Toward Sustainability, Lower Costs

OTC drug and personal care product firms can make their operations more sustainable by evaluating how they package products and their suppliers' environmental footprints, according to manufacturers and packaging suppliers

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105793

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel